+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 6Years - 11Years
All Genders
ID07817875

Study of Weekly Tirzepatide Versus Placebo for Treating Obesity in Children 6 to Under 12 Years Old

Led by Eli Lilly and Company · Updated on 2026-11-04

150

Participants Needed

82

Research Sites

156 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of tirzepatide added to healthy lifestyle changes in children aged 6 to under 12 years who have obesity. This phase 3 trial aims to evaluate how well tirzepatide works, its safety, and how the body processes the drug in this age group. Participants must have obesity defined by a body mass index BMI at or above the 95th percentile for their age and sex and have a history of at least one unsuccessful attempt to lose weight through structured diet and exercise. Participants are randomly assigned to receive either tirzepatide or a placebo, both given as weekly subcutaneous injections. The main treatment period lasts about 104 weeks, during which participants also continue lifestyle interventions. Those who complete this primary phase may have the option to continue receiving tirzepatide treatment for an additional 156 weeks while maintaining lifestyle changes. During the study, participants attend regular visits for assessments including measurements of BMI, body weight, waist circumference, blood pressure, cholesterol, glucose, insulin, liver enzymes, and quality of life questionnaires. Safety monitoring includes evaluating potential side effects and drug levels in the body. Overall participation can last up to about 260 weeks, combining the main treatment and extension periods.

CONDITIONS

Brief Title

Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)

Research Team

T

Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or

P

Physicians interested in becoming principal investigators please contact

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here